A Randomized, Crossover Study to Evaluate the Overall Safety and Tolerability of Paliperidone Palmitate Injected in the Deltoid or Gluteus Muscle in Patients With Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2017
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 01 Sep 2009 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 31 Aug 2009 Results published in Progress in Neuro-Psychopharmacology & Biological Psychiatry.
- 12 Jun 2008 Status change